Cargando…
Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers
Osteopontin (OPN) is a secreted glycoprotein, that belongs to the non-structural extracellular matrix (ECM), and its over expression in human prostate cancer has been associated with disease progression, androgen independence and metastatic ability. Nevertheless, the pathophysiology of OPN in prosta...
Autores principales: | Mauri, Giorgio, Jachetti, Elena, Comuzzi, Barbara, Dugo, Matteo, Arioli, Ivano, Miotti, Silvia, Sangaletti, Sabina, Di Carlo, Emma, Tripodo, Claudio, Colombo, Mario P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826179/ https://www.ncbi.nlm.nih.gov/pubmed/26700622 http://dx.doi.org/10.18632/oncotarget.6678 |
Ejemplares similares
-
Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling
por: Rizzello, Celeste, et al.
Publicado: (2022) -
Microenvironment-Centred Dynamics in Aggressive B-Cell Lymphomas
por: Cacciatore, Matilde, et al.
Publicado: (2012) -
Oral administration of withaferin A inhibits carcinogenesis of prostate in TRAMP model
por: Suman, Suman, et al.
Publicado: (2016) -
Osteopontin and oral carcinogenesis
por: Kapoor, Shailendra
Publicado: (2008) -
Vamps & tramps /
por: Paglia, Camille, 1947-
Publicado: (2001)